(24/7 MARKET NEWS) – ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) is a clinical- stage specialty biopharmaceutical company that has been trading as a public listing for about one month. During that time, it has traded mostly lower, however it started to slightly reverse the trend almost two weeks ago and that reversal to the upside gained momentum yesterday.
ZyVersa closed yesterday at $2.52, a 52-cent gain (+26.00%), on volume of 279,379 shares traded and is already at $3.52, up $1.00 (+39.68%), on 250 thousand premarket shares.
Its trading range is $1.38 to $25.00. If it can trade above $4 and maintain strong trading volume, it appears to have minor resistance to as high as the $10 trading level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
